Is the COVID-19 Pandemic a Good Time to Include Aspergillus Molecular Detection to Categorize Aspergillosis in ICU Patients? A Monocentric Experience.

MLA

Gangneux, Jean-Pierre, et al. “Is the COVID-19 Pandemic a Good Time to Include Aspergillus Molecular Detection to Categorize Aspergillosis in ICU Patients? A Monocentric Experience.” Journal of Fungi, vol. 6, no. 3, Sept. 2020, pp. 1–11. EBSCOhost, https://doi.org/10.3390/jof6030105.

APA

Gangneux, J.-P., Reizine, F., Guegan, H., Pinceaux, K., Le Balch, P., Prat, E., Pelletier, R., Belaz, S., Le Souhaitier, M., Le Tulzo, Y., Seguin, P., Lederlin, M., Tadié, J.-M., & Robert-Gangneux, F. (2020). Is the COVID-19 Pandemic a Good Time to Include Aspergillus Molecular Detection to Categorize Aspergillosis in ICU Patients? A Monocentric Experience. Journal of Fungi, 6(3), 1–11. https://doi.org/10.3390/jof6030105

Chicago

Gangneux, Jean-Pierre, Florian Reizine, Hélène Guegan, Kieran Pinceaux, Pierre Le Balch, Emilie Prat, Romain Pelletier, et al. 2020. “Is the COVID-19 Pandemic a Good Time to Include Aspergillus Molecular Detection to Categorize Aspergillosis in ICU Patients? A Monocentric Experience.” Journal of Fungi 6 (3): 1–11. doi:10.3390/jof6030105.